The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-hydroxy-3-methyl-1-((4-((2-methylquinolin-4-yl)methoxy)phenyl)sulfonyl)piperidine-3-carboxamide ID: ALA4097996
PubChem CID: 137660408
Max Phase: Preclinical
Molecular Formula: C24H31N3O5S
Molecular Weight: 473.60
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(COc2ccc(S(=O)(=O)N3CCCC(C)(C(=O)NO)C3)cc2)c2c(n1)CCCC2
Standard InChI: InChI=1S/C24H31N3O5S/c1-17-14-18(21-6-3-4-7-22(21)25-17)15-32-19-8-10-20(11-9-19)33(30,31)27-13-5-12-24(2,16-27)23(28)26-29/h8-11,14,29H,3-7,12-13,15-16H2,1-2H3,(H,26,28)
Standard InChI Key: YNDARFSNHRNMJO-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
21.2964 -10.0086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7130 -10.7253 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.1253 -10.0060 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5755 -11.1378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5755 -11.9628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2875 -12.3711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9996 -11.9628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9996 -11.1378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2875 -10.7211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4285 -11.1419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4238 -11.9710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1385 -12.3876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8581 -11.9762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8585 -11.1439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1433 -10.7311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5716 -12.3906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5695 -13.2155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2830 -13.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2792 -14.4556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9917 -14.8698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7082 -14.4589 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9944 -13.2192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7059 -13.6323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4154 -13.2248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4197 -12.4027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7081 -11.9897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9923 -12.3988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9894 -15.6947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8598 -10.7274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8573 -9.9024 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1465 -11.1419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4308 -10.7315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5713 -10.3128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
4 9 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 2 1 0
2 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
13 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 23 1 0
22 18 1 0
22 23 2 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
20 28 1 0
4 29 1 0
29 30 2 0
29 31 1 0
31 32 1 0
4 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 473.60Molecular Weight (Monoisotopic): 473.1984AlogP: 3.14#Rotatable Bonds: 6Polar Surface Area: 108.83Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.83CX Basic pKa: 6.55CX LogP: 2.81CX LogD: 2.74Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -0.94
References 1. Ouvry G, Berton Y, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Chambon S, Comino C, Deprez B, Duvert D, Duvert G, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Pascau J, Pinto A, Polge G, Reitz A, Reversé K, Rosignoli C, Taquet N, Hennequin LF.. (2017) Identification of novel TACE inhibitors compatible with topical application., 27 (8): [PMID:28274635 ] [10.1016/j.bmcl.2017.02.035 ]